CNMD•benzinga•
UPDATE: CONMED Raises FY22 Sales Guidance From $1.075B-$1.125B To $1.105B-$1.15B vs $1.09B Est. Adj. EPS From $3.60-$3.85 To $3.50-$3.65 vs $3.69 Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga